Evidence map›Paper›PMID 25157627›Full record

ArticlePloS one2014

Analysis of POFUT1 gene mutation in a Chinese family with Dowling-Degos disease.

Mingfei Chen, Yi Li, Hong Liu, Xi'an Fu, Yiongxiang Yu, Gongqi Yu, Chuan Wang, Fangfang Bao, Herty Liany, Zhenzhen Wang and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. EOGT andBiochemical Society transactions · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Mingfei ChenInstitute of Dermatology and Department of Dermatology at No.1 Hospital, Anhui Medical University, Hefei, Anhui, China; Shandong Provincial Institute of Dermatology and Venereology, Jinan, Shandong, China; Shandong Provincial Key Lab for Dermatovenereology, Jinan, Shandong, China.
Yi LiDepartment of Human Genetics, Genome Institute of Singapore, Singapore, Republic of Singapore.
Hong LiuShandong Provincial Institute of Dermatology and Venereology, Jinan, Shandong, China; Shandong Provincial Key Lab for Dermatovenereology, Jinan, Shandong, China.
Xi'an FuShandong Provincial Institute of Dermatology and Venereology, Jinan, Shandong, China; Shandong Provincial Key Lab for Dermatovenereology, Jinan, Shandong, China.
Yiongxiang YuShandong Provincial Institute of Dermatology and Venereology, Jinan, Shandong, China; Shandong Provincial Key Lab for Dermatovenereology, Jinan, Shandong, China.
Gongqi YuShandong Provincial Institute of Dermatology and Venereology, Jinan, Shandong, China; Shandong Provincial Key Lab for Dermatovenereology, Jinan, Shandong, China.
Chuan WangShandong Provincial Institute of Dermatology and Venereology, Jinan, Shandong, China; Shandong Provincial Key Lab for Dermatovenereology, Jinan, Shandong, China.
Fangfang BaoShandong Provincial Institute of Dermatology and Venereology, Jinan, Shandong, China; Shandong Provincial Key Lab for Dermatovenereology, Jinan, Shandong, China.
Herty LianyDepartment of Human Genetics, Genome Institute of Singapore, Singapore, Republic of Singapore.
Zhenzhen WangShandong Provincial Institute of Dermatology and Venereology, Jinan, Shandong, China; Shandong Provincial Key Lab for Dermatovenereology, Jinan, Shandong, China.
Zhongxiang ShiShandong Provincial Hospital for Skin Diseases, Jinan, Shandong, China; Shandong Provincial Medical Center for Dermatovenereology, Jinan, Shandong, China.
Dizhan ZhangShandong Provincial Hospital for Skin Diseases, Jinan, Shandong, China; Shandong Provincial Medical Center for Dermatovenereology, Jinan, Shandong, China.
Guizhi ZhouShandong Provincial Institute of Dermatology and Venereology, Jinan, Shandong, China; Shandong Provincial Medical Center for Dermatovenereology, Jinan, Shandong, China.
Jianjun LiuDepartment of Human Genetics, Genome Institute of Singapore, Singapore, Republic of Singapore.
Furen ZhangShandong Provincial Institute of Dermatology and Venereology, Jinan, Shandong, China; Shandong Provincial Hospital for Skin Diseases, Jinan, Shandong, China; Shandong Provincial Key Lab for Dermatovenereology, Jinan, Shandong, China; Shandong Provincial Medical Center for Dermatovenereology, Jinan, Shandong, China.
Shandong Provincial Institute of Dermatology and Venereology · CNGenome Institute of Singapore · SGAnhui Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dowling-Degos disease (DDD) is an autosomal dominant genodermatosis characterized by reticular pigmented anomaly mainly affecting flexures. Though KRT5 has been identified to be the causal gene of DDD, the heterogeneity of this disease was displayed: for example, POFUT1 and POGLUT1 were recently identified and confirmed to be additional pathogenic genes of DDD. To identify other DDD causative genes, we performed genome-wide linkage and exome sequencing analyses in a multiplex Chinese DDD family, in which the KRT5 mutation was absent. Only a novel 1-bp deletion (c.246+5delG) in POFUT1 was found. No other novel mutation or this deletion was detected in POFUT1 in a second DDD family and a sporadic DDD case by Sanger Sequencing. The result shows the genetic-heterogeneity and complexity of DDD and will contribute to the further understanding of DDD genotype/phenotype correlations and to the pathogenesis of this disease.

Indexed as

MutationAsian PeopleBase SequenceExomeFemaleFucosyltransferasesGenetic LinkageHumansHyperpigmentationMalePedigreeSequence DeletionSkin Diseases, GeneticSkin Diseases, PapulosquamousFucosyltransferasespolypeptide fucosyltransferase

Identifiers

PMID25157627
PMCPMC4144801
OpenAlexW1974763411

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.